Lichen planus is a chronic inflammatory dermatosis that can affect the skin, mucous membranes and nails. Cutaneous lichen planus lesions are best described by the “six Ps” – purple pruritic polygonal planar papules and plaques. Mucous membrane lesions are commonly associated with cutaneous lichen planus. Ocular involvement with lichen planus is rare and conjunctival involvement usually predominates, it can however be visually devastating. Ocular lichen planus often progresses to extensive conjunctival scarring which can be impossible to distinguish clinically from other cicatrising conjunctivitis, requiring histopathological confirmation. Here we review the ocular pathology of this condition.
MohebbiMMirghorbaniMBanafshe AfshanA,et al.Lichen Planus in ocular surface: major presentations and treatments. Ocul Immunol Inflamm2019; 27(6): 987–994.
2.
BochKLanganEAKridinK, et al.Lichen Planus. Front Med (Lausanne)2021; 8: 737813.
3.
LiCTangXZhengX, et al.Global prevalence and incidence estimates of oral lichen Planus: a systematic review and meta-analysis. JAMA Dermatol2020; 156(2): 172–181.
4.
KattaR. Lichen Planus. Am Fam Physician2000; 1(11): 3319–3324.
RheeMKMoothaVV. Bilateral keratoconjunctivitis associated with lichen planus. Cornea.2004; 23: 100–105.
7.
ShengyuanLSongpoYWenW, et al.Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis. Arch Dermatol.2009; 145: 1040–1047.
8.
MahboobiNAgha-HosseiniFLankaraniKB. Hepatitis C virus and lichen planus the real association. Hepat Mon2010; 10: 161–164.
GorouhiFDavariPFazelN. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. ScientificWorldJournal2014; 2014: 742826.
11.
RagazAAckermanAB. Evolution, maturation, and regression of lesions of lichen planus. New observations and correlations of clinical and histologic findings. Am J Dermatopathol.1981; 3: 5–25.
12.
CarboneTNasorriFPenninoD, et al.CD56 High CD16 - NK cell involvement in cutaneous lichen planus. Eur J Dermatol.2010; 20: 724–730.
13.
FlierJBoorsmaDMvan BeekPJ, et al.Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol2001; 194: 398–405.
14.
UsatineRPTinitiganM. Diagnosis and treatment of lichen Planus. Am Fam Physician2011; 84: 53–60.
15.
CribierBFrancesCChosidowO. Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol1998; 134: 1521–1530.
16.
IoannidesDVakirlisEKemenyL, et al.European S1 guidelines on the management of lichen planus: a cooperation of the European dermatology forum with the European academy of dermatology and venereology. J Eur Acad Dermatol Venereol2020; 34(7): 1403–1414.
17.
HolloPSzakonyiJKissD, et al.Successful treatment of lichen planus with Adalimumab. Acta Derm Venereol2012; 92(4): 385–386.
18.
KnisleyRRPetropolisAAMackeyVT. Lichen planus pemphigoides treated with ustekinumab. Cutis.2017; 100: 415–418.
19.
BelfiorePDi FedeOCabibiD, et al.Prevalence of vulval lichen planus in a cohort of women with oral lichen planus: an interdisciplinary study. Br J Dermatol2006; 155(5): 994–998.
EisenDCarrozzoMBagan SebastianJV,et al.Number V oral lichen planus: clinical features and management. Oral Dis2005; 11(6): 338–349.
22.
LavanyaNJayanthiPRaoUK,et al.Oral lichen planus: an update on pathogenesis and treatment. J Oral Maxillofac Pathol2011; 15(2): 127–132.
23.
LuRZengXHanQ, et al.Overexpression and selectively regulatory roles of IL-23/IL-17 axis in the lesions of oral lichen planus. Mediators Inflamm2014; 2014: 701094.
24.
IijimaWOhtaniHNakayamaT, et al.Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism. Am J Pathol2003; 163: 261–268.
SilvermanSGorskyMLozada-NurF,et al.A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol1991; 72: 665–670.
27.
AghbariSMHAbushoukAIAttiaA, et al.Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol2017; 68: 92–102.
28.
Gonzalez-MolesMARuiz-AvilaIGonzalez-RuizL, et al.Malignant transformation risk of oral lichen planus: a systematic review and comprehensive meta-analysis. Oral Oncol2019; 96: 121–130.
EisenDEllisCNDuellEA, et al.Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med1990; 323: 290–294.
31.
CrosbyMBCrosbyCVWojnoTH,et al.Conjunctival lichen planus in a patient with herpes simplex virus keratitis. Cornea2009; 28(8): 936–937.
32.
Rozas MuñozEMartínez-EscalaMEJuanpereN, et al.Isolated conjunctival lichen planus: a diagnostic challenge. Arch Dermatol2011; 147: 465–467.
33.
HuervaV. Lichen planus on the ocular surface. Cutan Ocul Toxicol2015; 34(3): 232–233.
34.
CromptonDO. Immuno-Suppressive drug treatment of Keratitis Sicca, including an example of lichen Planus of the Conjunctiva. Aust NZ J Surg1968; 38(2): 143–146.
35.
ThorneJEJabsDANikolskaiaOV, et al.Lichen planus and cicatrizing conjunctivitis: characterization of five cases. Am J Ophthalmol2003; 136(2): 239–243.
Gomez-ElizondoDELopez-MartinezMRuiz-LozanoRE, et al.Corneal perforation associated with isolated ocular lichen planus: a case report. Eur J Ophthalmol2021 Nov; 31(6): NP9–NP12.
BrewerJDEkdawiNSTorgersonRR, et al.Lichen planus and cicatricial conjunctivitis: disease course and response to therapy of 11 patients. J Eur Acad Dermatol Venereol2011; 25(1): 100–104.
40.
HahnJMMeislerDMLowderCY, et al.Cicatrizing conjunctivitis associated with paraneoplastic lichen Planus. Am J Ophthalmol2000; 129(1): 98–99.
41.
TuncaACalikogluEAktasD, et al.Oral lichen planus: an unusual cause of facial and abducens nerve paralysis associated with conjunctival and oesophageal involvement. J Eur Acad Dermatol Venereol2004; 18(5): 630–633.
42.
ShoughySS. Unusual ocular presentation in a patient with lichen planus. Can J Ophthalmol2018; 53(3): e122–e1e4.
43.
IgrasEKennedySMacDermottEJ,et al.Isolated ocular lichen planus in a child. J AAPOS2015; 19(4): 381–383.
44.
BevansSLTheosAJFowlerPG, et al.Pediatric ocular lichen planus and lichen planopilaris: one new case and a review of the literature. Pediatr Dermatol2018; 35(6): 859–863.
45.
ItinPHBuechnerSARufliT. Lichen planus of the eyelids. Dermatology1995; 191(4): 350–351.
46.
SanliBCetinENBirF, et al.Conjunctival impression cytology, ocular surface and tear-film changes in patients with lichen planus. Clin Exp Dermatol2012; 37(4): 341–345.
47.
WebberNKSetterfieldJFLewisFM,et al.Lacrimal canalicular duct scarring in patients with lichen Planus. Arch Dermatol2012; 148: 224–227.
RadfordCFRauzSWilliamsGP, et al.Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom. Eye (Lond)2012; 26(9): 1199–1208.
51.
BernardPVaillantLLabeilleB, et al.Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol1995; 131: 48–52.
52.
ZillikensDWeverSRothA, et al.Incidence of Autoimmune Subepidermal Blistering Dermatoses in a Region of Central Germany. Arch Dermatol1995 Aug; 131(8): 957–958.
53.
GrauAESetterfieldJSawVP. How to do conjunctival and buccal biopsies to investigate cicatrising conjunctivitis: improving the diagnosis of ocular mucous membrane pemphigoid. Br J Ophthalmol2013; 97(4): 530–531.
54.
DartJK. The 2016 bowman lecture conjunctival curses: scarring conjunctivitis 30 years on. Eye (Lond)2017; 31(2): 301–332.
55.
SpaideRFWardDL. Conjunctival biopsy in the diagnosis of sarcoidosis. Br J Ophthalmol.1990; 74: 469–471.
56.
ThorneJEAnhaltGJJabsDA. Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology2004; 111(1): 45–52.
57.
ChanLSAhmedARAnhaltGJ, et al.The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol2002; 138: 370–379.
58.
PowerWJNevesRARodriguezA, et al.Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular Cicatricia1 pemphigoid. Ophthalmology1995; 102(8): 1158–1163.
59.
SchmidtERashidHMarzanoAV, et al.European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European academy of dermatology and venereology - part II. J Eur Acad Dermatol Venereol2021; 35(10): 1926–1948.
60.
ShteinRMShenJFKuoAN, et al.Autologous Serum-based eye drops for treatment of ocular surface disease: a report by the American academy of ophthalmology. Ophthalmology2020; 127(1): 128–133.
61.
TsubotaKGotoEShimmuraS,et al.Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology1999; 106(10): 1984–1989.
TsubotaKGotoEFujitaH, et al.Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol1999 Apr; 83(4): 390–395.
64.
SemeraroFForbiceEBragaO, et al.Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies. Biomed Res Int2014; 2014: 826970.
65.
PanQAngelinaAZambranoA, et al.Autologous serum eye drops for dry eye. Cochrane Database Syst Rev2013 Aug 27; 8(8): CD009327.
66.
CelebiARUlusoyCMirzaGE. The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study. Graefes Arch Clin Exp Ophthalmol2014; 252(4): 619–626.
67.
HwangJChungS-HJeonS, et al.Comparison of clinical efficacies of autologous Serum eye drops in patients with primary and secondary Sjogren syndrome. Cornea2014; 33: 663–667.
68.
NeumannRDuttCJFosterCS. Immunohistopathologic features and therapy of conjunctival lichen Planus. Am J Ophthalmol1993; 115(4): 494–500.
69.
PakravanMKlesertTRAkpekEK. Isolated lichen planus of the conjunctiva. Br J Ophthalmol2006; 90(10): 1325–1326.
70.
TatlipinarSAkpekEK. Topical ciclosporin in the treatment of ocular surface disorders. Br J Ophthalmol2005; 89(10): 1363–1367.
71.
JirsovaKJonesGLA. Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting-a review. Cell Tissue Bank2017; 18(2): 193–204.
72.
LeeSBLiDQTanDT, et al.Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res2000; 20(325-334).
73.
TsengSCLiDQMaX. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol1999; 179: 325–335.
74.
SolomonARosenblattMMonroyD, et al.Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol2001; 85: 444–449.
75.
SolomonAEspanaEMTsengSC. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology.2003; 110: 93–100.
76.
TsengSCDi PascualeMALiuDT, et al.Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology2005; 112(5): 896–903.
77.
FaridMLeeN. Ocular surface reconstruction with keratolimbal allograft for the treatment of severe or recurrent symblepharon. Cornea2015; 34: 632–636.
78.
Sant’ AnnaAEHazarbassanovRMde FreitasD,et al.Minor salivary glands and labial mucous membrane graft in the treatment of severe symblepharon and dry eye in patients with Stevens-Johnson syndrome. Br J Ophthalmol2012; 96(2): 234–239.
79.
CretaraEAMSwanRTHillRH. Diagnosis, treatment, and surgical repair in a case of isolated conjunctival lichen Planus causing cicatricial entropion. Ophthal Plast Reconstr Surg2017; 33(6): e162–e1e3.
